David Shaw’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32M | Sell |
2,194,758
-1,969,425
| -47% | -$19M | 0.02% | 1013 |
|
|
2026
Q1 | $30.9M | Sell |
4,164,183
-1,133,345
| -21% | -$11.9M | 0.02% | 907 |
|
|
2025
Q4 | $62.3M | Buy |
5,297,528
+2,000,123
| +61% | +$21.6M | 0.03% | 603 |
|
|
2025
Q3 | $25.5M | Buy |
3,297,405
+2,362,229
| +253% | +$16.5M | 0.01% | 1019 |
|
|
2025
Q2 | $6.84M | Buy |
+935,176
| New | +$7.55M | ﹤0.01% | 1789 |
|
|
2025
Q1 | – | Sell |
-39,909
| Closed | -$658K | – | 4571 |
|
|
2024
Q4 | $658K | Sell |
39,909
-19,819
| -33% | -$308K | ﹤0.01% | 3452 |
|
|
2024
Q3 | $881K | Sell |
59,728
-106,828
| -64% | -$1.67M | ﹤0.01% | 3368 |
|
|
2024
Q2 | $2.31M | Buy |
166,556
+21,268
| +15% | +$302K | ﹤0.01% | 2532 |
|
|
2024
Q1 | $2.28M | Sell |
145,288
-248,891
| -63% | -$3.84M | ﹤0.01% | 2529 |
|
|
2023
Q4 | $6.38M | Sell |
394,179
-382,283
| -49% | -$6.26M | 0.01% | 1718 |
|
|
2023
Q3 | $9.55M | Sell |
776,462
-117,493
| -13% | -$1.75M | 0.01% | 1317 |
|
|
2023
Q2 | $14.4M | Buy |
893,955
+69,974
| +8% | +$1.15M | 0.01% | 1082 |
|
|
2023
Q1 | $14.3M | Sell |
823,981
-164,198
| -17% | -$2.34M | 0.02% | 1107 |
|
|
2022
Q4 | $9.13M | Buy |
988,179
+354,978
| +56% | +$3.31M | 0.01% | 1517 |
|
|
2022
Q3 | $5.45M | Sell |
633,201
-375,885
| -37% | -$3.73M | 0.01% | 1989 |
|
|
2022
Q2 | $8.22M | Buy |
1,009,086
+979,787
| +3,344% | +$9.35M | 0.01% | 1572 |
|
|
2022
Q1 | $356K | Buy |
+29,299
| New | +$617K | ﹤0.01% | 4568 |
|
|
2021
Q2 | – | Sell |
-9,497
| Closed | -$421K | – | 4921 |
|
|
2021
Q1 | $458K | Sell |
9,497
-19,939
| -68% | -$1.04M | ﹤0.01% | 3545 |
|
|
2020
Q4 | $1.58M | Buy |
+29,436
| New | +$1.33M | ﹤0.01% | 2703 |
|
|
2020
Q3 | – | Sell |
-10,120
| Closed | -$314K | – | 4038 |
|
|
2020
Q2 | $314K | Buy |
+10,120
| New | +$280K | ﹤0.01% | 3607 |
|
|
2019
Q4 | – | Sell |
-10,700
| Closed | -$205K | – | 4104 |
|
|
2019
Q3 | $205K | Buy |
+10,700
| New | +$251K | ﹤0.01% | 3611 |
|
|
2019
Q1 | – | Sell |
-333,609
| Closed | -$4.21M | – | 3810 |
|
|
2018
Q4 | $4.21M | Buy |
333,609
+284,201
| +575% | +$4.24M | 0.01% | 1627 |
|
|
2018
Q3 | $758K | Sell |
49,408
-21,900
| -31% | -$303K | ﹤0.01% | 2860 |
|
|
2018
Q2 | $935K | Buy |
+71,308
| New | +$785K | ﹤0.01% | 2736 |
|
|
2016
Q3 | – | Sell |
-27,497
| Closed | -$221K | – | 3483 |
|
|
2016
Q2 | $221K | Sell |
27,497
-42,407
| -61% | -$340K | ﹤0.01% | 3157 |
|
|
2016
Q1 | $471K | Sell |
69,904
-110,665
| -61% | -$728K | ﹤0.01% | 2816 |
|
|
2015
Q4 | $1.42M | Buy |
180,569
+43,191
| +31% | +$316K | ﹤0.01% | 2397 |
|
|
2015
Q3 | $787K | Sell |
137,378
-84,598
| -38% | -$524K | ﹤0.01% | 2764 |
|
|
2015
Q2 | $1.2M | Buy |
221,976
+121,440
| +121% | +$626K | ﹤0.01% | 2559 |
|
|
2015
Q1 | $470K | Buy |
100,536
+61,488
| +157% | +$267K | ﹤0.01% | 3083 |
|
|
2014
Q4 | $163K | Buy |
+39,048
| New | +$179K | ﹤0.01% | 3841 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
David Shaw's NEO Position: Q2 2026 in Review
David Shaw reduced its NeoGenomics (NEO) stake by 47% in Q2 2026, selling an estimated $19M and leaving 2,194,758 shares worth $32M. The position accounts for 0.02% of the portfolio, ranked #1013.
David Shaw first reported a position in NEO in Q4 2014 and has held it in 31 quarters since. The position peaked at $62.3M in Q4 2025. 265 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- David Shaw held 2,194,758 shares of NeoGenomics worth $32M as of Q2 2026.
- David Shaw sold 1,969,425 NeoGenomics shares in Q2 2026, an estimated $19M.
- NeoGenomics made up 0.02% of David Shaw's portfolio in Q2 2026, its #1013 holding.
- David Shaw first reported a position in NeoGenomics in Q4 2014 and has held it in 31 quarters since.
- David Shaw's NeoGenomics position peaked at $62.3M in Q4 2025.
- 265 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.